What is the current price and market cap of 2228.HK stock?

As of pre-market 19 Mar 2026, 2228.HK stock is at **HK$10.09** and the market cap is about **HK$43.42 billion** on the HKSE. Volume today is **41.31M** shares versus an average of **70.84M**.

What forecast does Meyka AI give for 2228.HK stock?

Meyka AI's forecast model projects a yearly price of **HK$10.66**, implying roughly **+5.60%** upside from **HK$10.09**. Forecasts are model-based projections and not guarantees.

How does 2228.HK stock look on valuation and fundamentals?

2228.HK shows trailing PE **9.61**, EPS **HK$1.05**, and price-to-book **4.76**, with negative free cash flow per share **-0.13**. Strong R&D spend and high P/S indicate growth expectations but also execution risk.

When is XtalPi’s next earnings announcement for 2228.HK stock?

XtalPi’s next earnings announcement is scheduled for **25 Mar 2026**. Investors typically watch that report for revenue guidance, R&D updates, and contract wins impacting 2228.HK stock.

HK Stocks

2228.HK XtalPi pre-market: HK$10.09 ahead of 25 Mar earnings report: key AI drug discovery signals

ByHuzaifa Zahoor March 19, 2026

2228.HK stock trades at HK$10.09 in Hong Kong pre-market on 19 Mar 2026, up 1.31% from the previous close as investors position ahead of XtalPi’s earnings on 25 Mar 2026. XtalPi Holdings Ltd (2228.HK) combines AI-driven drug discovery and lab automation across China, the US and Europe. Today’s volume sits at 41.31M shares versus a 50-day average of 11.37 and a 200-day average of 9.68, keeping the stock inside a short-term consolidation range. We review valuation, technicals, Meyka AI grade, and model forecasts for actionable AI-stock perspective.